Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Tectonic Therapeutic, Inc. (TECX)
USD32.97
-1.84 (-5.30%)
US NASDAQ Healthcare Biotechnology
Address
490 Arsenal Way 2472
Watertown, MA, US
Watertown, MA, US
CEO
Alise S. Reicin
Website
tectonictx.com
IPO
2018-06-21
CIK 1681087 ISIN US8789721086
Also trades on
NASDAQ Global Market · TECX (USD)
NASDAQ Global Select · AVRO (USD)
Description
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD32.97
-1.84 (-5.30%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
201.8K
Beta
0.10
Float Shares
11.20M
Free Float %
59.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.10% | -4.08% | -10.42% | +21.18% | +45.92% | +31.93% | +32.88% | +258.33% | -73.91% | -92.65% | -92.65% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
32.97
Low
60.00
+82.0%
Consensus
67.50
+104.8%
Median
67.50
+104.8%
High
75.00
+127.5%
DCF (Unlevered)
13.73
-58.4%
DCF (Levered)
13.78
-58.2%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 7 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | 1 |
75.00
+127.5%
|
| Last Quarter | 1 |
75.00
+127.5%
|
| Last Year | 2 |
67.50
+104.8%
|
| All Time | 2 |
67.50
+104.8%
|
Quality scores
Altman Z-Score
17.85
Safe zone
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-3.1% Q1'26: -44.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +5,922.1% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+24.1% Q1'26: +9.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.02× Q1'26: -0.04× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 EPS Ana. |
Dec 2027 8 EPS Ana. |
Dec 2028 8 EPS Ana. |
Dec 2029 3 Rev. Ana. 6 EPS Ana. |
Dec 2030 6 Rev. Ana. 6 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
—
— – —
|
—
— – —
|
—
— – —
|
41.67M
41.67M – 41.67M
|
139.66M
139.66M – 139.66M
+235.2% YoY
|
| EBITDA |
-56.23M
|
-71.48M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-57.88M
|
-72.86M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-57.98M
est: -65.98M (+12.1%)
|
-74.15M
est: -74.15M (+0.0%)
|
-101.24M
-102.87M – -85.30M
-36.5% YoY
|
-97.27M
-136.35M – -58.19M
+3.9% YoY
|
-174.18M
-188.25M – -45.30M
-79.1% YoY
|
-124.25M
-124.25M – -124.25M
+28.7% YoY
|
-84.51M
-84.51M – -84.51M
+32.0% YoY
|
| SGA |
16.65M
|
20.55M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-3.93
est: -8.08 (+51.3%)
|
-4.05
est: -4.17 (+2.8%)
|
-5.18
-5.61 – -4.66
-24.3% YoY
|
-5.50
-7.44 – -3.18
-6.3% YoY
|
-6.17
-10.27 – -2.47
-12.1% YoY
|
-6.78
-6.78 – -6.78
-9.9% YoY
|
-4.61
-4.61 – -4.61
+32.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 3/5 | 1/5 | 1/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
Owner's Earnings history not available.
Owner alignment
Owner's Earnings TTM
—
OE per share TTM
—
Owner's Yield
—
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
—
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
14
Total invested
36.14M
Insider transactions (90d)
1
Beneficial owners (>5%)
50
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Timothy A. Springer | 4.24M | 28.80% | 4.24M | — | 4.24M | — | IN, OO | United States | 2024-06-26 | ↗ |
| 2 | Braden M Leonard | 3.97M | 9.00% | 420.0K | 3.55M | 420.0K | 3.55M | IN | Delaware | 2023-07-24 | ↗ |
| 3 | BML Investment Partners, L.P. | 3.55M | 8.00% | — | 3.55M | — | 3.55M | PN | Delaware | 2023-07-24 | ↗ |
| 4 | Andrew J. M. Spokes | 3.12M | 7.10% | — | 3.12M | — | — | IN | United Kingdom | 2023-02-17 | ↗ |
| 5 | Daniel S. Short | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 6 | David T. Kim | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 7 | Edric C. Saito | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 8 | Hannah E. Dunn | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 9 | John R. Warren | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 10 | Joshua J. Dapice | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 11 | Mark C. Wehrly | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 12 | Michael B. Fisch | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 13 | Michael G. Linn | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 14 | Nicolas Giauque | 3.12M | 7.10% | — | 3.12M | — | — | IN | France | 2023-02-17 | ↗ |
| 15 | Philip D. Dreyfuss | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 16 | Rajiv A. Patel | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 17 | Richard B. Fried | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 18 | Thomas G. Roberts, Jr. | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 19 | Varun N. Gehani | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 20 | William Seybold | 3.12M | 7.10% | — | 3.12M | — | — | IN | United States | 2023-02-17 | ↗ |
| 21 | Farallon Partners, L.L.C. | 2.86M | 6.50% | — | 2.86M | — | — | OO | Delaware | 2023-02-17 | ↗ |
| 22 | Newtyn Management, LLC | 2.73M | 6.10% | 2.73M | — | 2.73M | — | IA | New York | 2024-02-14 | ↗ |
| 23 | TANG CAPITAL PARTNERS, LP | 2.71M | 6.10% | — | 2.71M | — | 2.71M | — | DELAWARE | 2023-06-06 | ↗ |
| 24 | Federated Hermes, Inc. | 2.60M | 5.95% | 2.60M | — | 2.60M | — | HC | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 25 | Rhodora J. Donahue | 2.60M | 5.95% | — | 2.60M | — | 2.60M | IN | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 26 | Thomas R. Donahue | 2.60M | 5.95% | — | 2.60M | — | 2.60M | IN | Citizenship or place of Organization | 2022-02-14 | ↗ |
| 27 | K2 & ASSOCIATES INVESTMENT MANAGEMENT INC. | 2.24M | 5.12% | — | 2.24M | — | 2.24M | CO | Ontario, CANADA | 2022-08-01 | ↗ |
| 28 | K2 Genpar 2017 Inc. | 2.24M | 5.12% | — | 2.24M | — | 2.24M | CO | Ontario, CANADA | 2022-08-01 | ↗ |
| 29 | L.P. | 2.24M | 5.12% | — | 2.24M | — | 2.24M | PN | Ontario, CANADA | 2022-08-01 | ↗ |
| 30 | SHAWN KIMEL INVESTMENTS, INC. | 2.24M | 5.12% | — | 2.24M | — | 2.24M | CO | Ontario, CANADA | 2022-08-01 | ↗ |
| 31 | Abigail P. Johnson | 2.02M | 13.68% | — | — | 2.02M | — | IN | Delaware | 2024-07-10 | ↗ |
| 32 | FMR LLC | 2.02M | 13.68% | 2.02M | — | 2.02M | — | HC | Delaware | 2024-07-10 | ↗ |
| 33 | (1) BlackRock, Inc. | 2.00M | 4.60% | 1.92M | — | 2.00M | — | HC | Delaware | 2022-07-08 | ↗ |
| 34 | TAS Partners LLC | 1.55M | 10.50% | 1.55M | — | 1.55M | — | OO | Delaware | 2024-06-26 | ↗ |
| 35 | Farallon Capital Offshore Investors II, L.P. | 1.10M | 2.50% | — | 1.10M | — | — | PN | Cayman Islands | 2023-02-17 | ↗ |
| 36 | VV Manager II, LLC | 1.03M | 7.00% | — | 1.03M | — | 11.00 | OO | — | 2024-06-27 | ↗ |
| 37 | Vida Ventures II, LLC | 1.00M | 6.80% | — | 1.00M | — | 11.00 | OO | — | 2024-06-27 | ↗ |
| 38 | EcoR1 Capital, LLC | 849.1K | 11.00% | — | 849.1K | — | — | IA, OO | Delaware | 2024-07-01 | ↗ |
| 39 | Oleg Nodelman | 849.1K | 11.00% | — | 849.1K | — | — | HC, IN | Delaware | 2024-07-01 | ↗ |
| 40 | EcoR1 Capital Fund Qualified, L.P. | 783.2K | 11.00% | — | 783.2K | — | — | PN | Delaware | 2024-07-01 | ↗ |
| 41 | Farallon Capital Institutional Partners, L.P. | 672.3K | 1.50% | — | 672.3K | — | — | PN | California | 2023-02-17 | ↗ |
| 42 | Farallon Capital Partners, L.P. | 563.9K | 1.30% | — | 563.9K | — | — | PN | California | 2023-02-17 | ↗ |
| 43 | Farallon Capital F5 Master I, L.P. | 253.2K | 0.60% | — | 253.2K | — | — | PN | Cayman Islands | 2023-02-17 | ↗ |
| 44 | Farallon F5 (GP), L.L.C. | 253.2K | 0.60% | — | 253.2K | — | — | OO | Delaware | 2023-02-17 | ↗ |
| 45 | Farallon Capital Institutional Partners II, L.P. | 205.9K | 0.50% | — | 205.9K | — | — | PN | California | 2023-02-17 | ↗ |
| 46 | Farallon Institutional (GP) V, L.L.C. | 140.1K | 0.30% | — | 140.1K | — | — | OO | Delaware | 2023-02-17 | ↗ |
| 47 | Four Crossings Institutional Partners V, L.P. | 140.1K | 0.30% | — | 140.1K | — | — | PN | Delaware | 2023-02-17 | ↗ |
| 48 | Farallon Capital Institutional Partners III, L.P. | 112.7K | 0.30% | — | 112.7K | — | — | PN | Delaware | 2023-02-17 | ↗ |
| 49 | Farallon Capital (AM) Investors, L.P. | 64.2K | 0.10% | — | 64.2K | — | — | PN | Delaware | 2023-02-17 | ↗ |
| 50 | Vida Ventures II-A, LLC | 27.8K | 0.20% | — | 27.8K | — | 11.00 | OO | — | 2024-06-27 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
14
-97 vs prev Q
New positions
2
Closed positions
95
Increased
6
Reduced
3
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | FMR LLC | 2.81M +661.0 (+0.0%) | 58.56M +14.5M (+33.0%) | 15.00% +0.004 pp | 0.00% +0.001 pp | USD20.66 +1.0% | 7 qtrs — |
| 2 | ABRDN PLC | 1.14M +785.6K (+220.6%) | 23.82M +18.2M (+326.2%) | 6.10% +4.199 pp | 0.04% +0.028 pp | USD19.25 +8.4% | 2 qtrs — |
| 3 | BRAIDWELL LP | 927.5K +190.7K (+25.9%) | 19.35M +7.8M (+67.4%) | 4.96% +1.019 pp | 0.62% +0.276 pp | USD16.75 +24.5% | 2 qtrs — |
| 4 | BAKER BROS. ADVISORS LP | 903.4K +803.4K (+803.4%) | 18.84M +17.3M (+1,101.1%) | 4.83% +4.293 pp | 0.11% +0.099 pp | USD20.51 +1.7% | 4 qtrs — |
| 5 | BLACKROCK, INC. | 854.4K +26.5K (+3.2%) | 17.82M +4.8M (+37.2%) | 4.57% +0.142 pp | 0.00% +0.000 pp | USD23.27 -10.4% | 6 qtrs — |
| 6 | 5AM VENTURE MANAGEMENT, LLC | 606.7K +95.0K (+18.6%) | 12.65M +4.6M (+57.6%) | 3.24% +0.508 pp | 3.98% +1.038 pp | USD16.68 +25.1% | 7 qtrs — |
| 7 | VANGUARD GROUP INC | 599.9K +30.4K (+5.3%) | 12.51M +3.6M (+40.1%) | 3.21% +0.163 pp | 0.00% +0.000 pp | USD23.05 -9.5% | 7 qtrs — |
| 8 | ORBIMED ADVISORS LLC | 574.6K +574.6K (+100.0%) | 11.99M +12.0M (+100.0%) | 3.07% +3.071 pp | 0.25% +0.246 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 9 | POINT72 ASSET MANAGEMENT, L.P. | 492.3K +70.6K (+16.7%) | 10.27M +3.7M (+55.2%) | 2.63% +0.377 pp | 0.01% +0.000 pp | USD17.52 +19.1% | 4 qtrs — |
| 10 | VESTAL POINT CAPITAL, LP | 328.0K +328.0K (+100.0%) | 6.84M +6.8M (+100.0%) | 1.75% +1.753 pp | 0.23% +0.233 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 11 | BOLLARD GROUP LLC | 303.0K +— (+0.0%) | 6.32M +1.6M (+33.0%) | 1.62% +0.000 pp | 0.16% +0.046 pp | USD17.71 +17.8% | 4 qtrs — |
| 12 | MILLENNIUM MANAGEMENT LLC | 300.8K +62.7K (+26.3%) | 6.28M +2.5M (+67.9%) | 1.61% +0.335 pp | 0.00% +0.001 pp | USD18.13 +15.1% | 5 qtrs — |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 263.6K -5.8K (-2.2%) | 5.50M +1.3M (+30.1%) | 1.41% -0.031 pp | 0.00% +0.000 pp | USD21.23 -1.7% | 7 qtrs — |
| 14 | PALE FIRE CAPITAL SE | 261.0K +1.3K (+0.5%) | 5.45M +1.4M (+33.6%) | 1.39% +0.007 pp | 0.37% -0.081 pp | USD15.72 +32.7% | 2 qtrs — |
| 15 | PERCEPTIVE ADVISORS LLC | 250.0K +250.0K (+100.0%) | 5.22M +5.2M (+100.0%) | 1.34% +1.336 pp | 0.09% +0.093 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 16 | PROSIGHT MANAGEMENT, LP | 235.0K -144.3K (-38.0%) | 4.90M -1.0M (-17.6%) | 1.26% -0.771 pp | 1.01% -0.375 pp | USD17.92 +16.4% | 7 qtrs — |
| 17 | OPALEYE MANAGEMENT INC. | 214.7K +214.7K (+100.0%) | 4.48M +4.5M (+100.0%) | 1.15% +1.148 pp | 0.59% +0.591 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 18 | KENNEDY CAPITAL MANAGEMENT LLC | 209.2K +449.0 (+0.2%) | 4.36M +1.1M (+33.2%) | 1.12% +0.002 pp | 0.09% +0.020 pp | USD15.70 +32.9% | 2 qtrs — |
| 19 | STATE STREET CORP | 209.1K +43.6K (+26.3%) | 4.36M +1.8M (+68.0%) | 1.12% +0.233 pp | 0.00% +0.000 pp | USD21.11 -1.2% | 7 qtrs — |
| 20 | WOODLINE PARTNERS LP | 200.0K +— (+0.0%) | 4.17M +1.0M (+33.0%) | 1.07% +0.000 pp | 0.02% +0.001 pp | USD26.12 -20.1% | 6 qtrs — |
| 21 | SQUAREPOINT OPS LLC | 199.6K +134.2K (+205.1%) | 4.16M +3.1M (+305.6%) | 1.07% +0.717 pp | 0.00% +0.003 pp | USD20.10 +3.8% | 4 qtrs — |
| 22 | WELLS FARGO & COMPANY/MN | 120.4K +17.9K (+17.5%) | 2.51M +904.0K (+56.2%) | 0.64% +0.096 pp | 0.00% +0.000 pp | USD19.31 +8.0% | 7 qtrs — |
| 23 | D. E. SHAW & CO., INC. | 120.3K +120.3K (+100.0%) | 2.51M +2.5M (+100.0%) | 0.64% +0.643 pp | 0.00% +0.001 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 24 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 111.2K +98.2K (+754.2%) | 2.32M +2.1M (+1,035.6%) | 0.59% +0.525 pp | 0.02% +0.016 pp | USD20.25 +3.0% | 2 qtrs — |
| 25 | DIADEMA PARTNERS LP | 100.6K +600.0 (+0.6%) | 2.10M +529.5K (+33.7%) | 0.54% +0.003 pp | 0.36% -0.040 pp | USD15.72 +32.7% | 2 qtrs — |
| 26 | MORGAN STANLEY | 94.4K -10.3K (-9.8%) | 1.97M +326.7K (+19.9%) | 0.50% -0.055 pp | 0.00% +0.000 pp | USD18.28 +14.1% | 7 qtrs — |
| 27 | GOLDMAN SACHS GROUP INC | 92.7K -4.2K (-4.3%) | 1.93M +414.0K (+27.2%) | 0.50% -0.022 pp | 0.00% +0.000 pp | USD15.69 +33.0% | 5 qtrs — |
| 28 | KOTLER KEVIN | 80.0K +80.0K (+100.0%) | 1.67M +1.7M (+100.0%) | 0.43% +0.428 pp | 0.39% +0.390 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 29 | KNOTT DAVID M JR | 74.0K +— (+0.0%) | 1.54M +382.6K (+33.0%) | 0.40% +0.000 pp | 0.71% +0.247 pp | USD18.70 +11.6% | 4 qtrs — |
| 30 | NORTHERN TRUST CORP | 72.3K -11.0K (-13.2%) | 1.51M +201.3K (+15.4%) | 0.39% -0.059 pp | 0.00% +0.000 pp | USD22.46 -7.1% | 6 qtrs — |
| 31 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 71.7K +27.8K (+63.3%) | 1.49M +806.2K (+117.1%) | 0.38% +0.148 pp | 0.00% +0.002 pp | USD22.78 -8.4% | 6 qtrs — |
| 32 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 65.9K -82.2K (-55.5%) | 1.37M -949.0K (-40.8%) | 0.35% -0.439 pp | 0.00% 0.000 pp | USD15.69 +33.0% | 2 qtrs — |
| 33 | GSA CAPITAL PARTNERS LLP | 63.3K +63.3K (+100.0%) | 1.32M +1.3M (+100.0%) | 0.34% +0.338 pp | 0.11% +0.114 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 34 | RAYMOND JAMES FINANCIAL INC | 54.6K +2.7K (+5.1%) | 1.14M +324.2K (+39.8%) | 0.29% +0.014 pp | 0.00% +0.000 pp | USD19.43 +7.4% | 5 qtrs — |
| 35 | CITADEL ADVISORS LLC | 44.7K +44.7K (+100.0%) | 932.4K +932.4K (+100.0%) | 0.24% +0.239 pp | 0.00% +0.000 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 36 | PFM HEALTH SCIENCES, LP | 42.7K +42.7K (+100.0%) | 891.2K +891.2K (+100.0%) | 0.23% +0.228 pp | 0.09% +0.089 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 37 | SECTORAL ASSET MANAGEMENT INC | 42.3K -150.5K (-78.1%) | 881.4K -2.1M (-70.9%) | 0.23% -0.804 pp | 0.71% -1.160 pp | USD17.84 +16.9% | 3 qtrs — |
| 38 | JUMP FINANCIAL, LLC | 39.5K +39.5K (+100.0%) | 824.0K +824.0K (+100.0%) | 0.21% +0.211 pp | 0.01% +0.010 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 39 | SCHONFELD STRATEGIC ADVISORS LLC | 39.1K +39.1K (+100.0%) | 815.8K +815.8K (+100.0%) | 0.21% +0.209 pp | 0.00% +0.004 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 40 | WELLINGTON MANAGEMENT GROUP LLP | 37.4K +17.0 (+0.0%) | 779.7K +193.5K (+33.0%) | 0.20% +0.000 pp | 0.00% +0.000 pp | USD17.75 +17.5% | 4 qtrs — |
| 41 | ALDEBARAN CAPITAL, LLC | 37.4K -1.1K (-3.0%) | 779.2K +175.1K (+29.0%) | 0.20% -0.006 pp | 0.70% +0.144 pp | USD15.90 +31.2% | 7 qtrs — |
| 42 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 32.5K +103.0 (+0.3%) | 677.1K +169.4K (+33.4%) | 0.17% +0.001 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 5 qtrs — |
| 43 | UBS GROUP AG | 31.2K -35.2K (-53.0%) | 651.1K -391.6K (-37.6%) | 0.17% -0.188 pp | 0.00% 0.000 pp | USD22.09 -5.6% | 6 qtrs — |
| 44 | MARSHALL WACE, LLP | 30.9K +5.8K (+23.3%) | 644.9K +251.5K (+63.9%) | 0.17% +0.031 pp | 0.00% +0.000 pp | USD17.36 +20.2% | 4 qtrs — |
| 45 | ADAR1 CAPITAL MANAGEMENT, LLC | 30.0K -26.0K (-46.4%) | 625.9K -252.8K (-28.8%) | 0.16% -0.139 pp | 0.05% -0.037 pp | USD16.58 +25.8% | 7 qtrs — |
| 46 | BIT CAPITAL GMBH | 30.0K +30.0K (+100.0%) | 625.8K +625.8K (+100.0%) | 0.16% +0.160 pp | 0.02% +0.023 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 47 | MONIMUS CAPITAL MANAGEMENT, LP | 26.6K +2.7K (+11.3%) | 554.8K +179.9K (+48.0%) | 0.14% +0.014 pp | 0.37% +0.135 pp | USD18.47 +12.9% | 4 qtrs — |
| 48 | BANK OF NEW YORK MELLON CORP | 25.9K -275.0 (-1.1%) | 539.4K +129.4K (+31.6%) | 0.14% -0.002 pp | 0.00% +0.000 pp | USD19.73 +5.7% | 3 qtrs — |
| 49 | BARCLAYS PLC | 22.4K +21.0K (+1,457.5%) | 468.2K +424.5K (+972.2%) | 0.12% +0.112 pp | 0.00% +0.000 pp | USD21.74 -4.0% | 7 qtrs — |
| 50 | AQUATIC CAPITAL MANAGEMENT LLC | 22.3K +22.3K (+100.0%) | 464.4K +464.4K (+100.0%) | 0.12% +0.119 pp | 0.01% +0.013 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 51 | JANE STREET GROUP, LLC | 19.3K -9.4K (-32.7%) | 403.0K -47.6K (-10.6%) | 0.10% -0.051 pp | 0.00% +0.000 pp | USD15.69 +33.0% | 5 qtrs — |
| 52 | QUEST PARTNERS LLC | 18.2K +10.9K (+149.2%) | 379.4K +264.9K (+231.3%) | 0.10% +0.058 pp | 0.02% +0.014 pp | USD19.30 +8.1% | 4 qtrs — |
| 53 | ALPS ADVISORS INC | 15.4K +15.4K (+100.0%) | 320.6K +320.6K (+100.0%) | 0.08% +0.082 pp | 0.00% +0.002 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 54 | SEI INVESTMENTS CO | 15.3K +15.3K (+100.0%) | 318.1K +318.1K (+100.0%) | 0.08% +0.082 pp | 0.00% +0.000 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 55 | NUVEEN, LLC | 14.3K +— (+0.0%) | 298.4K +74.0K (+33.0%) | 0.08% +0.000 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 3 qtrs — |
| 56 | RHUMBLINE ADVISERS | 14.2K -1.8K (-11.2%) | 296.1K +45.2K (+18.0%) | 0.08% -0.010 pp | 0.00% +0.000 pp | USD19.84 +5.1% | 7 qtrs — |
| 57 | VIRTUS INVESTMENT ADVISERS, INC. | 13.5K +8.4K (+165.5%) | 280.8K +201.3K (+252.9%) | 0.07% +0.045 pp | 0.08% +0.054 pp | USD19.65 +6.2% | 4 qtrs — |
| 58 | PALUMBO WEALTH MANAGEMENT LLC | 13.0K +13.0K (+100.0%) | 272.1K +272.1K (+100.0%) | 0.07% +0.070 pp | 0.07% +0.067 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 59 | MAREX GROUP PLC | 12.5K +12.5K (+100.0%) | 260.8K +260.8K (+100.0%) | 0.07% +0.067 pp | 0.00% +0.002 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 60 | CLARIUS GROUP, LLC | 10.1K +— (+0.0%) | 211.3K +52.4K (+33.0%) | 0.05% +0.000 pp | 0.01% +0.003 pp | USD46.17 -54.8% | 5 qtrs — |
| 61 | DIMENSIONAL FUND ADVISORS LP | 10.1K +10.1K (+100.0%) | 210.2K +210.2K (+100.0%) | 0.05% +0.054 pp | 0.00% +0.000 pp | USD20.86 +0.0% | 6 qtrs — |
| 62 | QUADRATURE CAPITAL LTD | 10.0K -16.3K (-61.9%) | 208.9K -202.5K (-49.2%) | 0.05% -0.087 pp | 0.00% -0.003 pp | USD15.69 +33.0% | 2 qtrs — |
| 63 | BANK OF AMERICA CORP /DE/ | 9.2K +2.9K (+44.9%) | 192.4K +92.6K (+92.7%) | 0.05% +0.015 pp | 0.00% +0.000 pp | USD18.68 +11.7% | 7 qtrs — |
| 64 | SIMPLEX TRADING, LLC | 9.1K +8.4K (+1,090.4%) | 190.7K +178.7K (+1,489.2%) | 0.05% +0.045 pp | 0.00% +0.000 pp | USD20.43 +2.1% | 2 qtrs — |
| 65 | DEUTSCHE BANK AG\ | 7.6K +7.6K (+100.0%) | 158.3K +158.3K (+100.0%) | 0.04% +0.041 pp | 0.00% +0.000 pp | USD20.86 +0.0% | 3 qtrs — |
| 66 | METLIFE INVESTMENT MANAGEMENT, LLC | 6.7K +— (+0.0%) | 140.3K +34.8K (+33.0%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 3 qtrs — |
| 67 | CLEARSTEAD ADVISORS, LLC | 6.5K +5.0K (+333.3%) | 135.6K +112.1K (+476.1%) | 0.03% +0.027 pp | 0.00% +0.001 pp | USD19.72 +5.8% | 7 qtrs — |
| 68 | ALPHACENTRIC ADVISORS LLC | 6.5K +6.5K (+100.0%) | 135.1K +135.1K (+100.0%) | 0.03% +0.035 pp | 0.13% +0.135 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 69 | CANADA PENSION PLAN INVESTMENT BOARD | 6.3K +6.3K (+100.0%) | 131.4K +131.4K (+100.0%) | 0.03% +0.034 pp | 0.00% +0.000 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 70 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 6.1K -830.0 (-12.1%) | 126.2K +18.3K (+16.9%) | 0.03% -0.004 pp | 0.01% +0.001 pp | USD29.28 -28.8% | 5 qtrs — |
| 71 | JPMORGAN CHASE & CO | 5.8K -145.0 (-2.4%) | 120.6K +27.6K (+29.7%) | 0.03% -0.001 pp | 0.00% +0.000 pp | USD24.28 -14.1% | 7 qtrs — |
| 72 | LOS ANGELES CAPITAL MANAGEMENT LLC | 6.4K +6.4K (+100.0%) | 112.8K +112.8K (+100.0%) | 0.03% +0.034 pp | 0.00% +0.000 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 73 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 5.1K -55.0 (-1.1%) | 105.9K +25.4K (+31.5%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 3 qtrs — |
| 74 | NEW YORK STATE COMMON RETIREMENT FUND | 5.0K +— (+0.0%) | 104.3K +25.9K (+33.0%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 3 qtrs — |
| 75 | NISA INVESTMENT ADVISORS, LLC | 5.0K +5.0K (+100.0%) | 104.3K +104.3K (+100.0%) | 0.03% +0.027 pp | 0.00% +0.000 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 76 | BNP PARIBAS ARBITRAGE, SNC | 2.8K +397.0 (+16.4%) | 58.8K +20.8K (+54.7%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD19.97 +4.5% | 7 qtrs — |
| 77 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 2.6K +— (+0.0%) | 55.0K +13.6K (+33.0%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 3 qtrs — |
| 78 | AMERITAS INVESTMENT PARTNERS, INC. | 1.1K +— (+0.0%) | 23.4K +5.8K (+33.0%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 3 qtrs — |
| 79 | LEGAL & GENERAL GROUP PLC | 1.1K +— (+0.0%) | 21.9K +5.4K (+32.9%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 3 qtrs — |
| 80 | CITIGROUP INC | 1.0K -125.0 (-10.8%) | 21.5K +3.4K (+18.6%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD21.86 -4.6% | 6 qtrs — |
| 81 | RUSSELL INVESTMENTS GROUP, LTD. | 929.00 +19.0 (+2.1%) | 19.4K +5.1K (+35.7%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD15.79 +32.1% | 2 qtrs — |
| 82 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 909.00 +186.0 (+25.7%) | 19.0K +7.6K (+67.2%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD34.28 -39.1% | 5 qtrs — |
| 83 | TOWER RESEARCH CAPITAL LLC (TRC) | 752.00 -713.0 (-48.7%) | 15.7K -7.3K (-31.8%) | 0.00% -0.004 pp | 0.00% 0.000 pp | USD22.21 -6.1% | 7 qtrs — |
| 84 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 676.00 -8.0 (-1.2%) | 14.1K +3.4K (+31.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.69 +33.0% | 2 qtrs — |
| 85 | HIGHMARK WEALTH MANAGEMENT LLC | 587.00 +587.0 (+100.0%) | 12.2K +12.2K (+100.0%) | 0.00% +0.003 pp | 0.01% +0.005 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 86 | GROUP ONE TRADING, L.P. | 541.00 +368.0 (+212.7%) | 11.3K +8.6K (+315.8%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD19.21 +8.6% | 2 qtrs — |
| 87 | STERLING CAPITAL MANAGEMENT LLC | 537.00 -96.0 (-15.2%) | 11.2K +1.3K (+12.8%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD17.34 +20.3% | 3 qtrs — |
| 88 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 500.00 -500.0 (-50.0%) | 10.4K -5.3K (-33.5%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD15.69 +33.0% | 2 qtrs — |
| 89 | CWM, LLC | 466.00 +82.0 (+21.4%) | 10.0K +4.0K (+66.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD28.04 -25.6% | 6 qtrs — |
| 90 | ROYAL BANK OF CANADA | 521.00 +235.0 (+82.2%) | 10.0K +5.0K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD19.13 +9.0% | 7 qtrs — |
| 91 | FARTHER FINANCE ADVISORS, LLC | 373.00 +373.0 (+100.0%) | 7.8K +7.8K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 92 | GF FUND MANAGEMENT CO. LTD. | 367.00 -36.0 (-8.9%) | 7.7K +1.3K (+21.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD39.47 -47.1% | 5 qtrs — |
| 93 | AMALGAMATED BANK | 345.00 -30.0 (-8.0%) | 7.0K +1.0K (+16.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 3 qtrs — |
| 94 | UBS ASSET MANAGEMENT AMERICAS INC | 173.00 +173.0 (+100.0%) | 3.6K +3.6K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD20.86 +0.0% | 1 qtrs NEW |
| 95 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 164.00 +— (+0.0%) | 3.4K +848.0 (+33.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.70 +17.9% | 4 qtrs — |
| 96 | VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC | 107.00 +— (+0.0%) | 2.2K +553.0 (+32.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD19.87 +5.0% | 3 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 54 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech Clinical Trials ETF BBC | 0.70% | 402.2K | 0.65% |
| 2 | ALPS Medical Breakthroughs ETF SBIO | 0.33% | 708.2K | 0.50% |
| 3 | iShares Micro-Cap ETF IWC | 0.08% | 1.18M | 0.60% |
| 4 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.05% | 33.6K | 0.35% |
| 5 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.05% | 502.3K | 0.35% |
| 6 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.04% | 206.4K | 0.40% |
| 7 | Invesco Nasdaq Biotechnology ETF IBBQ | 0.04% | 33.3K | 0.19% |
| 8 | ProShares Ultra Nasdaq Biotechnology BIB | 0.03% | 21.8K | 1.19% |
| 9 | iShares Biotechnology ETF IBB | 0.02% | 2.33M | 0.44% |
| 10 | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF GSSC | 0.02% | 233.0K | 0.20% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.50
Neutral
Ratio by volume
3.00
Bullish
Buys
1
Sells
2
Shares acquired
20.4K
Shares disposed
2.1K
Cash buys
—
Cash sales
2.00
Net activity
+18,335
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-04 | Ruddy Marcella K. | Officer | S-Sale | D | Common Stock | 1,065 | 30.00 | 32.0K | 67,682 | D | ↗ |
| 2026-04-01 | Ruddy Marcella K. | Officer | S-Sale | D | Common Stock | 1,000 | 31.05 | 31.1K | 68,747 | D | ↗ |
| 2026-04-01 | Nader Francois | Director | A-Award | A | Stock Option (Right to Buy) | 20,400 | 30.78 | 627.9K | 20,400 | D | ↗ |
| 2026-03-06 | Ruddy Marcella K. | Officer | S-Sale | D | Common Stock | 10,000 | 30.00 | 300.0K | 69,747 | D | ↗ |
| 2026-03-06 | McNamara Peter | Officer | M-Exempt | A | Common Stock | 215 | 14.71 | 3.2K | 61,547 | D | ↗ |
| 2026-03-04 | Schwabish Marc | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 17,750 | 27.41 | 486.5K | 17,750 | D | ↗ |
| 2026-03-04 | Ruddy Marcella K. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 24,250 | 27.41 | 664.7K | 24,250 | D | ↗ |
| 2026-03-04 | REICIN ALISE | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 69,250 | 27.41 | 1.90M | 69,250 | D | ↗ |
| 2026-03-04 | McNamara Peter | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 21,000 | 27.41 | 575.6K | 21,000 | D | ↗ |
| 2026-03-04 | Lochner Daniel | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 24,250 | 27.41 | 664.7K | 24,250 | D | ↗ |
| 2026-03-03 | McNamara Peter | Officer | S-Sale | D | Common Stock | 1,649 | 22.06 | 36.4K | 37,482 | D | ↗ |
| 2026-02-11 | REICIN ALISE | Director / Officer | P-Purchase | A | Common Stock | 2,500 | 21.10 | 52.8K | 237,547 | D | ↗ |
| 2026-02-10 | Schwabish Marc | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 4,500 | 2.38 | 10.7K | 82,014 | D | ↗ |
| 2026-02-10 | Lochner Daniel | Officer | P-Purchase | A | Common Stock | 6,000 | 21.61 | 129.7K | 32,044 | D | ↗ |
| 2026-02-04 | Schwabish Marc | Officer | F-InKind | D | Common Stock | 1,619 | 23.22 | 37.6K | 21,314 | D | ↗ |
| 2026-02-04 | Ruddy Marcella K. | Officer | F-InKind | D | Common Stock | 2,064 | 23.22 | 47.9K | 53,247 | D | ↗ |
| 2026-02-04 | REICIN ALISE | Director / Officer | F-InKind | D | Common Stock | 4,104 | 23.22 | 95.3K | 235,047 | D | ↗ |
| 2026-02-04 | McNamara Peter | Officer | F-InKind | D | Common Stock | 1,748 | 23.22 | 40.6K | 39,131 | D | ↗ |
| 2026-02-04 | Lochner Daniel | Officer | F-InKind | D | Common Stock | 2,077 | 23.22 | 48.2K | 26,044 | D | ↗ |
| 2025-12-31 | REICIN ALISE | Director / Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 10,966 | 2.38 | 26.1K | 22,957 | D | ↗ |
| 2025-12-22 | McNamara Peter | Officer | M-Exempt | A | Common Stock | 7,000 | 2.98 | 20.9K | 40,879 | D | ↗ |
| 2025-09-25 | Schwabish Marc | Officer | A-Award | A | Common Stock | 4,210 | 0.00 | — | 22,933 | D | ↗ |
| 2025-09-25 | Ruddy Marcella K. | Officer | A-Award | A | Common Stock | 5,370 | 0.00 | — | 55,311 | D | ↗ |
| 2025-09-25 | REICIN ALISE | Director / Officer | A-Award | A | Common Stock | 14,700 | 0.00 | — | 228,185 | D | ↗ |
| 2025-09-25 | McNamara Peter | Officer | A-Award | A | Common Stock | 4,550 | 0.00 | — | 33,879 | D | ↗ |
| 2025-09-25 | Lochner Daniel | Officer | A-Award | A | Common Stock | 5,430 | 0.00 | — | 28,121 | D | ↗ |
| 2025-06-20 | REICIN ALISE | Director / Officer | F-InKind | D | Common Stock | 859 | 19.81 | 17.0K | 213,485 | D | ↗ |
| 2025-06-09 | Vitorovic Stefan | Director | A-Award | A | Stock Option (Right to Buy) | 10,200 | 24.48 | 249.7K | 10,200 | D | ↗ |
| 2025-06-09 | Tipirneni Praveen P. | Director | A-Award | A | Stock Option (Right to Buy) | 10,200 | 24.48 | 249.7K | 10,200 | D | ↗ |
| 2025-06-09 | SPRINGER TIMOTHY A | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 10,200 | 24.48 | 249.7K | 10,200 | D | ↗ |
| 2025-06-09 | MCGUIRE TERRANCE | Director | A-Award | A | Stock Option (Right to Buy) | 10,200 | 24.48 | 249.7K | 10,200 | D | ↗ |
| 2025-06-09 | Donenberg Phillip B. | Director | A-Award | A | Stock Option (Right to Buy) | 10,200 | 24.48 | 249.7K | 10,200 | D | ↗ |
| 2025-04-11 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 9,478 | 16.31 | 154.6K | 4,334,846 | D | ↗ |
| 2025-04-10 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 8,092 | 16.73 | 135.4K | 4,325,368 | D | ↗ |
| 2025-04-09 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 857 | 15.23 | 13.1K | 4,317,276 | D | ↗ |
| 2025-04-07 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 87,500 | 17.10 | 1.50M | 4,313,558 | D | ↗ |
| 2025-04-07 | MCGUIRE TERRANCE | Director | S-Sale | D | Common Stock | 500,000 | 17.10 | 8.55M | 573,062 | I | ↗ |
| 2025-02-05 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 129,294 | 54.14 | 7.00M | 4,226,058 | D | ↗ |
| 2025-02-05 | Lochner Daniel | Officer | P-Purchase | A | Common Stock | 4,617 | 54.14 | 250.0K | 4,617 | D | ↗ |
| 2025-02-04 | Schwabish Marc | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 25,496 | 48.01 | 1.22M | 25,496 | D | ↗ |
| 2025-02-04 | Ruddy Marcella K. | Officer | A-Award | A | Common Stock | 17,876 | 0.00 | — | 49,941 | D | ↗ |
| 2025-02-04 | REICIN ALISE | Director / Officer | A-Award | A | Common Stock | 36,047 | 0.00 | — | 214,344 | D | ↗ |
| 2025-02-04 | McNamara Peter | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 27,530 | 48.01 | 1.32M | 27,530 | D | ↗ |
| 2025-02-04 | Lochner Daniel | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 32,862 | 48.01 | 1.58M | 32,862 | D | ↗ |
| 2025-01-28 | Schwabish Marc | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 2,700 | 2.38 | 6.4K | 86,514 | D | ↗ |
| 2024-12-09 | Schwabish Marc | Officer | M-Exempt | D | Employee Stock Option (Right to Buy) | 2,000 | 2.38 | 4.8K | 89,214 | D | ↗ |
| 2024-12-04 | REICIN ALISE | Director / Officer | A-Award | A | Common Stock | 11,717 | 0.00 | — | 178,297 | D | ↗ |
| 2024-12-03 | McNamara Peter | Officer | M-Exempt | A | Common Stock | 3,500 | 2.38 | 8.3K | 14,188 | D | ↗ |
| 2024-10-22 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 300,000 | 33.59 | 10.08M | 4,096,764 | D | ↗ |
| 2024-09-26 | SPRINGER TIMOTHY A | Director / 10% Owner | P-Purchase | A | Common Stock | 4,070 | 30.10 | 122.5K | 3,794,364 | D | ↗ |
| 2024-09-24 | SPRINGER TIMOTHY A | Director / 10% Owner | J-Other | A | Common Stock | 186,134 | 0.00 | — | 186,134 | I | ↗ |
| 2024-06-20 | Vitorovic Stefan | Director | A-Award | A | Common Stock | 1,000,900 | 0.00 | — | 1,000,900 | — | ↗ |
| 2024-06-20 | Tipirneni Praveen P. | Director | A-Award | A | Common Stock | 3,037 | 0.00 | — | 3,037 | — | ↗ |
| 2024-06-20 | Schwabish Marc | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-20 | SPRINGER TIMOTHY A | Director / 10% Owner | A-Award | A | Common Stock | 2,692,005 | 0.00 | — | 2,692,005 | — | ↗ |
| 2024-06-20 | Ruddy Marcella K. | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-20 | REICIN ALISE | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 23,380 | 5.38 | 125.8K | 23,380 | — | ↗ |
| 2024-06-20 | McNamara Peter | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 37,959 | 2.38 | 90.3K | 37,959 | — | ↗ |
| 2024-06-20 | MCGUIRE TERRANCE | Director | A-Award | A | Common Stock | 1,073,062 | 0.00 | — | 1,073,062 | — | ↗ |
| 2024-06-20 | Lochner Daniel | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 118,000 | 16.80 | 1.98M | 118,000 | — | ↗ |
| 2024-06-20 | Leonard Braden Michael | 10% Owner | J-Other | A | Common Stock | 400,355 | 0.00 | — | 400,355 | — | ↗ |
| 2024-06-20 | Donenberg Phillip B. | Director | A-Award | A | Stock Option (Right to Buy) | 11,760 | 16.80 | 197.6K | 11,760 | — | ↗ |
| 2024-06-20 | Cortis Christian | Officer | A-Award | A | Common Stock | 126,368 | 0.00 | — | 126,368 | — | ↗ |
Executive team
Top executives
Shares Outstanding
18.78M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Alise Reicin, M.D. President, CEO and Director | 640.8K | — | 1.95M | 4.37M | 372.5K | 17.8K | 7.35M | 85.97% | ↗ |
| 2 | 2025 | Daniel Lochner, M.B.A. Chief Financial Officer | 488.9K | — | 947.6K | 1.42M | 206.5K | 33.4K | 3.10M | 76.50% | ↗ |
| 3 | 2025 | Marcella K. Ruddy, M.D. Chief Medical Officer | 501.1K | — | 937.2K | 1.41M | 211.7K | 10.5K | 3.07M | 76.44% | ↗ |
| 4 | 2024 | Alise Reicin, M.D. President, CEO and Director | 606.2K | — | 600.8K | 4.29M | 392.2K | 10.3K | 5.90M | 82.92% | ↗ |
| 5 | 2024 | Daniel Lochner, M.B.A. Chief Financial Officer | 277.1K | — | — | 1.86M | 126.3K | 24.7K | 2.28M | 81.25% | ↗ |
| 6 | 2024 | Marcella K. Ruddy, M.D. Chief Medical Officer | 476.2K | — | — | 1.14M | 224.0K | 742.00 | 1.84M | 61.95% | ↗ |
| 7 | 2024 | Erik Ostrowski, M.B.A. Former President, Interim Chief Executive Officer, Chief Financial Officer and Treasurer | 254.1K | — | — | — | 829.3K | 9.9K | 1.09M | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alise S. Reicin | President, Chief Executive Officer, Secretary & Director | 1M | — |
| Daniel Lochner | Chief Financial Officer | 728.7K | male |
| Marcella K. Ruddy | Chief Medical Officer | 723.3K | — |
| Timothy A. Springer | Co-Founder & Independent Director | 24.0K | — |
| John Diener | Senior Vice President of Antibody Engineering & Protein Sciences | — | — |
| Marc Schwabish | Chief Business Officer | — | — |
| Geraldine Peters-Wiles | Senior Vice President of Human Resources | — | female |
| Peter McNamara | Chief Scientific Officer | — | — |
| Anthony Muslin | Chief Development Officer | — | male |
ESG Rating
ESG Score History
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for TECX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
